Benny Johnson

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Metastatic Colorectal Cancer

Placebo Controlled

Prognostic Factors

Ejection Fraction

Top Venues

Cancer research communications

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Van Karlyle Morris, Amir Jazaeri, Shannon N Westin, Curtis Pettaway, Solly George, Ryan W Huey, Michaela Grinsfelder, Aaron Shafer, Benny Johnson, David Vining, Ming Guo, Bryan Fellman, Michael Frumovitz
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers. The oncologist (2023)
Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria Serpas Higbie, Kanwal P S Raghav, Benny Johnson, Arvind N Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Edmund S Kopetz, Michael James Overman, Van Karlyle Morris
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer research communications 3 (12) (2023)
Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria Serpas Higbie, Kanwal P S Raghav, Benny Johnson, Arvind N Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Edmund S Kopetz, Michael James Overman, Van Karlyle Morris
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer research communications 3 (12) (2023)
Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria Serpas Higbie, Kanwal P S Raghav, Benny Johnson, Arvind N Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Edmund S Kopetz, Michael James Overman, Van Karlyle Morris
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer research communications 3 (12) (2023)
Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria Serpas Higbie, Kanwal P S Raghav, Benny Johnson, Arvind N Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Edmund S Kopetz, Michael James Overman, Van Karlyle Morris
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer research communications 3 (12) (2023)
Benny Johnson, Cara L Haymaker, Edwin R Parra, Luisa Maren Solis Soto, Xuemei Wang, Jane V Thomas, Arvind Dasari, Van K Morris, Kanwal Raghav, Eduardo Vilar, Bryan K Kee, Cathy Eng, Christine M Parseghian, Robert A Wolff, Younghee Lee, Daniele Lorenzini, Caddie Laberiano-Fernandez, Anuj Verma, Wenhua Lang, Ignacio I Wistuba, Andrew Futreal, Scott Kopetz, Michael J Overman
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). Journal for immunotherapy of cancer 10 (8) (2022)
Alexey V Sorokin, Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju C Manyam, Lawrence N Kwong, Benny Johnson, Van Karlyle Morris, Philip Jones, David G Menter, Michael S Lee, Edmund S Kopetz
Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6. Cancer research 82 (18) (2022)
Victoria Serpas Higbie, Jane E Rogers, Hyunsoo Hwang, Wei Qiao, Lianchun Xiao, Arvind N Dasari, Kerri Mola-Rudd, Van Karlyle Morris, Robert A Wolff, Kanwal P S Raghav, Ryan Huey, Christine M Parseghian, Jason A Willis, Edmund S Kopetz, Michael James Overman, Benny Johnson
Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience. The oncologist 27 (11) (2022)
Jenny E Chu, Benny Johnson, Laveniya Kugathasan, Van Karlyle Morris, Kanwal Raghav, Lucas A Swanson, Howard J Lim, Daniel J Renouf, Sharlene Gill, Robert Wolber, Aly Karsan, Scott Kopetz, David F Schaeffer, Jonathan M Loree
Population-based Screening for BRAF V600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (17) (2020)